| Rescula (Unoprostone isopropyl) Drug Information: Description ... Learn about the prescription medication Rescula (Unoprostone isopropyl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Rescula Glaucoma Drops - intromovie One of the newest glaucoma agent is the second in the family of prostaglandin analogs to be approved in this country: Rescula (unoprostone isopropyl 0.15%), marketed ... Read More |
| Rescula consumer information from Drugs.com Rescula (unoprostone) patient information. Detailed drug information for the consumer, includes dosage, Rescula side effects and more. Read More |
| Unoprostone - Wikipedia, the free encyclopedia Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, is marketed under the trade name Rescula (eyedrops, 0.15%) for the ... Read More |
| Rescula medical facts from Drugs.com Physician reviewed Rescula patient information - includes Rescula description, dosage and directions. Read More |
| Rescula (unoprostone isopropyl ophthalmic solution) 0.15% - Drug ... Drug information and side-effects for Rescula (unoprostone isopropyl ophthalmic solution) 0.15% Read More |
| Sucampo Pharmaceuticals Inc Acquires Rights to Sucampo Pharmaceuticals, Inc. Acquires Rights to Rescula for U.S. and Canada 4/24/2009 7:02:32 AM. BETHESDA, Md. & TOKYO--(BUSINESS WIRE)--Sucampo Pharmaceuticals ... Read More |
| RESCULA x Only (unoprostone isopropyl ophthalmic solution) 0.15% ... NDA 21-214 Rescula (unoprostone isopropyl ophthalmic solution) 0.15% Page 1 of 6 RESCULA Rx Only (unoprostone isopropyl ophthalmic solution) 0.15% Read More |
| RESCULA (Unoprostone) drug information from MPR RESCULA (Unoprostone) drug information for Glaucoma, Ocular hypertension from MPR including side effects, drug interactions, dosing, contraindications and warnings ... Read More |
| Newly Approved Drug Therapies (638) Rescula (unoprostone isopropyl ... Rescula (unoprostone isopropyl ophthalmic solution) 0.15% newly approved drug information on CenterWatch. Read More |
